Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 17,506 followers.

Open Access UCL Research: Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review https://t.co/xjMUxCafRN

10 Aug 2022

Reply Repost Favourite

New article: Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review https://t.co/Pw0SjmbN0V #pancreaticcancer #oncology https://t.co/0vcjv9Aki6

28 Jul 2022

Reply Repost Favourite

New article: Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review https://t.co/fhUHKvyUPp #prostatecancer #oncology https://t.co/vpimSiLQ2n

28 Jul 2022

Reply Repost Favourite

New Research: Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review https://t.co/1HDyPx5UnZ #pharmacology

12 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.